1Bamba H, Kondo Y, Wong RM, et al. Minimum inhibitory concentration of various single agents and the effect of their combinations against Helicobacter pylori, as estimated by a fast and simple in vitro assay method[ J 1. Gastroenterol, 1997,92 ( 4 ) : 659.
2Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa- associated lymphoid tissue type after eradication of Helicobacter pylori [ J ]. Lancet, 1993,342 ( 8871 ) :575.
3Ohara T, Goshi S, Taneike 1, et al. Inhibitory action of a novel proton pump inhibitor, Rabeprazole, and its thioether derivative against the growth and motility of clarithromycin- resistan Helicobacter pylori [ J ]. Helicobacter, 2001,6 ( 2 ) : 125.
4McGowan CC ,Cover TL,Blaser M J, The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism[J]. Gastroenterol, 1994, 107 (5) :1573.
5Sanaka M, Yamamoto T, Kuyama Y. Effects of proton pump inhibitors on gastric emptying: a systematic review [Jl. Dig Dis Sci,2010,55(9) :2431.
6Kerrigan DD, Mangnall YF, Read NW, et al. Influence of acid-pepsin secretion on gastric emptying of ~'~o|ids in humans : studies with cimetidine [ J ]. Gut, 1991,32 ( l 1 ) : 1295.
7Hunt JN, Stubbs DF. The volume and energy density of meals as determinants of gastric emptying [ J 3. J physiol, 1975,254( 1 ) :209.
8Jones DB, Howden CW, Bourget DW, et al. Acid suppression in duodenal ulcer: a meta-analysisi to define optimal dosing with antisceretory drugs[ J]. Gut, 1987,28 (9) :1120.
9Aronow HD, Steinhubl SR, Brennan DM, et al. Bleeding risk associated with 1 year of dual antiplatelet therapy after percutaneous coronary intervention:Insights from the Clopidogrel for the Reduction of Events During Observation(CREDO) trial [ J]. Am Heart J, 2009, 157 (2) :369.
10Bhattacharjee M,Bhattacharjee S, Gupta A, et al. Critical role of an endogenous gastric peroxidase in controlling oxidative damage in H. pylori-mediated and nonmediated gastric ulcer [ J ]. Free Radic boil Med, 2002,32 ( 8 ) : 731,.
二级参考文献48
1Fennerty MB. What are the treatment goals for helicobacter pylori infection? Gastroenterology 1997; 113 (Suppl): S120-125.
2Malfertheiner P, Megraud F, O;Morain C, Hungin AP, Jones R, Axon A, Graham DY, Tytgat G. European Helicobacter pylori Study Group (EHPSG). Current concepts in the management of helicobacter pylori infection-The Maastricht 2-2 000 Consensus report, Aliment Pharmacol Ther 2002; 16:167-180.
3Herrerias JM, Bujanda L, Pena D. Efficacy and cost study in Portugal and Spain of three different 7 day eradication regimens of Helicobacter pylori. Gastroenterology 1999; 116:A186.
4Spinzi GC, Bortoli A, Corbellini A. One Week therapy with omeprazole (PPY) or ranitidine bismuth citrate (RBC) and two antibiotics for the eradication of Helicobacter pylori in duodenal ulcer: a preliminary report. Gastroenterolgy 1998; 116:A294.
5Sung JY, Leung WK, Ling TK, Yung MY, Chan FK, Lee YT, Cheng AF, Chung SC. One week use of ranitidine bismuth citrate,amoxicillin and claritromycin for the treatment of Helicobacter pylori related duodenal ulcer. Aliment Pharmacol Ther 1998; 12:723-730.
6Susi D. The best treatment for Helicobacter pylori infection among for different 7 day triple therapies, Gut 1998; 43 (Suppl 2): A80.
7Peura DA. The report of the digestive health initiative international update conference on Helicobacter pylori. Gastroenterology 1997; 113:4-8.
9Pounder RE. New developments in H pylori eradication therapy. Scand J Gastroenterol 1997; 32 (suppl): 43-45.
10The European Helicobacter Pylori Study Group. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report. Gut 1997; 41:8-13.
